科拓生物股东拟合计减持不超5%股份

Group 1 - The core point of the article is that Keta Bio (300858.SZ) announced a share reduction plan from major shareholders, including Ningbo Shunyi and Ningbo Kehui Da, as well as director and vice president Qiao Xiangqian, who plan to collectively reduce their holdings by up to 5% of the company's shares [1] Group 2 - The shareholders involved hold more than 5% of the company's shares, indicating significant ownership and potential influence on the company's stock performance [1] - The announcement reflects a strategic decision by the shareholders, which may impact investor sentiment and market perception of Keta Bio [1] - The reduction plan is a common practice among shareholders, often aimed at liquidity or portfolio rebalancing [1]